Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRONG TREAT 1 to 4
2011-002784-24Phase 3Active
- Sponsor
- IRCCS Ospedale Sacro Cuore Don Calabria
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ivermectin in strongyloidiasis (2 arms), sponsored by IRCCS Ospedale Sacro Cuore Don Calabria. Primary endpoint: Clearance of strongyloidiasis at T2. Started Jul 2013; status: active.
02
Drugs
ivermectin
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on 2011-002784-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002784-24.